Fortrea Holdings Inc. (FTRE)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $1.95B
Last updated: Nov 17, 2026 at 11:06 AM ET
Fortrea Holdings Inc. (FTRE) P/E Ratio & Valuation History
Fortrea Holdings (FTRE) trades at 26.0x trailing earnings and 0.7x sales. Its forward P/E is 10.6x.
Current Multiples
Its forward P/E is below its trailing P/E, which implies earnings per share about 145.3% higher over the next year. Its free cash flow yield is 8.8%.
| Multiple | Value |
|---|---|
| P/E (trailing) | 26.0x |
| Forward P/E | 10.6x |
| Price to sales | 0.7x |
| Price to book | 3.6x |
| EV/EBITDA | 25.5x |
| Price to FCF | 11.3x |
| EV/FCF | 16.2x |
| PEG | 0.3 |
| FCF yield | 8.8% |
Valuation History
Over the 3 year ends shown, its P/E ranged from 24.9x in 2023 to 54.9x in 2024.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $17.25 | 41.1x | 0.6x | 2.8x |
| 2024 | $18.65 | 54.9x | 0.6x | 1.2x |
| 2023 | $34.90 | 24.9x | 1.1x | 1.8x |
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About FTRE
What is FTRE's forward P/E ratio?
Fortrea Holdings has a forward P/E ratio of 10.6x.
Is FTRE stock overvalued?
GNG's valuation label for FTRE is Fairly valued.
What is FTRE's price to sales ratio?
Fortrea Holdings has a price to sales ratio of 0.7x.
What is FTRE's PEG ratio?
Fortrea Holdings has a PEG ratio of 0.3.
FTRE pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors